GHULAM SHAIKH: Open Payments
NPI 1073571733 · GARNER, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 49 payments from 17 companies in 2025. Trend: 2023 $1,739 · 2024 $1,589 · 2025 $791
Food & beverage: $791
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $177 |
| AstraZeneca Pharmaceuticals LP | 9 | $157 |
| Novo Nordisk Inc | 7 | $126 |
| ABBVIE INC. | 3 | $71 |
| KYOWA KIRIN, INC. | 2 | $49 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| PFIZER INC. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: OTEZLA, Wegovy, FARXIGA, VRAYLAR, AIRSUPRA, CRYSVITA, REPATHA, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
